logo
Plus   Neg
Share
Email

United Technologies Q1 Profit From Cont. Ops. Up; Backs 2012 View - Quick Facts

United Technologies Corp. (UTX) reported first-quarter net income attributable to common shareowners of $330 million, lower than $1.01 billion last year.

Net income attributable to common shareowners from contnuing operations rose to $1.18 billion from last year's $967 million. Earnings per share from continuing operations were $1.31, up from $1.06 in the same quarter a year ago.

Earnings per share from discontinued operations were a loss of $0.94 in the quarter, reflecting the previously disclosed goodwill impairment charges for Rocketdyne and Clipper, as well as tax adjustments associated with the planned divestiture of the Hamilton Sundstrand Industrial businesses.

Results for the current quarter include $0.30 per share of net favorable one-time items, partially offset by $0.09 of restructuring costs. Earnings per share in the year ago quarter included $0.02 of restructuring costs. Net foreign currency translation and hedges at Pratt & Whitney Canada had an adverse impact of $0.02 in the quarter.

Excluding items, earnings per share were up 2 percent year over year.

On average, 21 analysts polled by Thomson Reuters expected the company to report earnings of $1.20 per share. Analysts' estimates typically exclude special items.

Sales for the quarter reached $12.42 billion, down 2 percent from the prior year, reflecting net divestitures of 2 points and adverse foreign currency translation of 1 point. Analysts estimated revenues of $12.71 billion.

Organic sales increased 1 percent from the year ago quarter.

Including Goodrich, the company still expects earnings from continuing operations in 2012 of $5.30 to $5.50 per share, up 0 to 4 percent. On the same basis, the company continues to expect sales of $61 billion to $62 billion. Analysts expect the company to earn $5.53 per share, on revenues of $62.22 billion.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
An administrative law judge has ruled that Minnesota regulators should approve Enbridge Inc.'s proposal to replace its aging Line 3 crude oil pipeline only if the company follows the existing route and not its preferred route. Enbridge has applied to replace its Line 3 pipeline from Alberta with new pipe along its existing route. In Minnesota, the planned route deviates from the existing route. CLICK HERE to see America's 10 Best-Selling Drugs Despite high drug costs, most of the top-selling drugs saw sales gains in 2017 compared to the prior year. A large number of the best-selling drugs are primarily for the treatment and management of cancer, diabetes, inflammatory disorders, and HIV... Most Americans have access to health care, though costs and services vary from state to state. However, higher costs do not necessarily translate into better results. The U.S. continues to be outperformed by other wealthy nations on several measures like life expectancy, disease burden and health...
Follow RTT